In one study, these were elevated in patients with peripheral arterial disease (PAD) compared to those with ischemic heart disease [86] and plasma levels of resistin and diastolic BP were predictors of new ischemic events and readmission for nonfatal myocardial infarction, heart failure, or critical limb ischemia in these patients. The gene discussed is RETN; the disease is coronary artery disorder.